Marksans Pharma Limited
Marksans Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: MARKSANS and BSE: 524404 (ISIN INE750C01026).
It has a market capitalisation of ₹13,733 crore, a last close of ₹303.05 on 2026-10-19, a one-year return of 71.2%.
Valuation: a price-to-earnings ratio of 26.58x, a price-to-book ratio of 4.54x, a dividend yield of 0.3%.
Profitability: return on equity of 15.2%, return on capital employed of 19.2%, an operating margin of 22.5%.
Growth: sales growth of 16.8% a year over three years, net profit growth of 16.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.01x, promoter holding of 43.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 13,733 |
| Last close | ₹303.05 |
| P/E (TTM) | 26.58x |
| P/B | 4.54x |
| Dividend yield | 0.3% |
| ROE (FY) | 15.2% |
| ROCE (FY) | 19.2% |
| Operating margin (TTM) | 22.5% |
| Sales growth, 3-year CAGR | 16.8% |
| Profit growth, 3-year CAGR | 16.4% |
| Debt / equity | 0.01x |
| Promoter holding | 43.9% |
| 1-year return | 71.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means